Obsession has officially topped Sinners as the highest-grossing original live-action film of the decade so far, with $371 million in global box office against a budget under $1 million. It is not a typo or a rounding trick. The movie was made for roughly $750,000 and still pulled in about $371 million at the global box office, while Sinners earned $370.3 million worldwide against a $90 million budget.

For decision-makers, that gap matters. These are not just two movies doing well. They represent two different risk profiles colliding in the same scoreboard. Obsession’s economics are a stress test for the “originals are too expensive and too unpredictable” narrative: a tiny budget original horror can outgross a much larger production, essentially swapping the usual order of financial power.

Now, the Obsession pitch is exactly the kind of premise that drives low-budget traction. Written and directed by Curry Barker, the film follows Bear (Michael Johnston), who buys a novelty wishing branch and wishes for his crush, Nikki (Indie Navarette), to love him more than anything in the world. The wish works, but something takes over Nikki, and the rest of the movie becomes a violent fight against whatever has taken hold of her. From a market lens, that is a clean, easy-to-market setup with a built-in escalation curve, which is one reason horror often travels well when budgets stay lean.

Obsession’s cast also reads like a practical mix of recognition and discovery: Cooper Tomlinson, Andy Richter, Megan Lawless, Haley Fitzgerald, and Darin Toonder round out the ensemble. The film is still in theaters, which is relevant because box office is both a revenue stream and a marketing engine. When a movie reaches a headline like “highest-grossing original live-action of the decade so far,” it can extend theater momentum by making late audiences curious and reminding everyone else that the release is not fading quietly.

Sinners, by comparison, is the prestige-heavy counterpart. Directed by Ryan Coogler, it earned $370.3 million worldwide against a $90 million budget, and it took home four out of a whopping 16 Oscar nominations. That Oscar haul also made it the most Oscar-nominated movie in history. The key takeaway here is not just that Sinners performed well. It performed well with a much larger spend and a major awards footprint, which is typically what helps studios justify scale. In other words, the scoreboard comparison is not between an art film and a niche horror. It is between two “high upside” original bets, and Obsession is the one with the dramatically smaller budget.

The Obsession franchise question adds another layer of boardroom relevance. When asked if Obsession will turn into a franchise, Barker told The Hollywood Reporter, “I don’t want to go straight into Obsession 2.” He also said, “I have such a cool idea for it that I won’t say. I’m not saying it has to be five, six years from now. But I think people would be just as excited for it if it came a little down the road. It’s a whirlwind, and I’m trying to figure it out.” That is a classic creator balance: protect what works, avoid immediate sequel dilution, and buy time to land the next version while the brand is hot.

Second-order implications here are subtle but real for peers running similar portfolios. A story-driven original horror that clears roughly $371 million on a production spend of about $750,000 is a template executives can pressure-test in development meetings. It suggests there is room for scale-light, concept-forward projects that do not require blockbuster budgets to create blockbuster outcomes. It also raises the bar for how studios measure “risk.” If an original can become the decade’s top-grossing live-action original with that kind of spend, then “originals are financially weaker” becomes a weaker argument, at least when the premise and execution land.

And for studios and investors watching release strategy, the release cadence matters too. Obsession is still in theaters, while Sinners is streaming now on HBO Max. That split highlights how the market is increasingly bifurcated: theatrical performance can establish cultural proof and momentum, while streaming distribution can translate that attention into longer-tail consumption. When the theatrical race is so tight, that translation from theater to streaming becomes part of the ROI math, not an afterthought.

Ultimately, the strategic stakes are straightforward: if Obsession really is the highest-grossing original live-action film of the decade so far, it is not just a victory lap for one horror title. It is a scoreboard shake-up for anyone funding originals. The message to boards and executives is that the economics of creativity can swing wildly in your favor, but only if you can identify the projects that combine a tight budget with an audience-ready premise and a release strategy that lets momentum compound.